<unk> , sold under the brand name Thioderon, is an orally active antiestrogen and anabolic–androgenic steroid (AAS) of the dihydrotestosterone (DHT) group which is marketed in Japan as an antineoplastic agent for the treatment of breast cancer. It is a prodrug of epitiostanol. The drug was patented and described in 1968.
Mepitiostane
Trilostane
Epitiostanol
Oprelvekin
Avatrombopag
Asfotase alfa
Tirbanibulin
Eptifibatide